IL12A, MPHOSPH9/CDK2AP1 and RGS1 Are Novel Multiple Sclerosis Susceptibility Loci

Overview

Journal Genes Immun

Date 2010 Jun 18

PMID 20555355

Citations 38

Affiliations

Soon will be listed here.

Abstract

A recent meta-analysis identified seven single-nucleotide polymorphisms (SNPs) with suggestive evidence of association with multiple sclerosis (MS). We report an analysis of these polymorphisms in a replication study that includes 8,085 cases and 7,777 controls. A meta-analysis across the replication collections and a joint analysis with the discovery data set were performed. The possible functional consequences of the validated susceptibility loci were explored using RNA expression data. For all of the tested SNPs, the effect observed in the replication phase involved the same allele and the same direction of effect observed in the discovery phase. Three loci exceeded genome-wide significance in the joint analysis: RGS1 (P value=3.55 x 10(-9)), IL12A (P=3.08 x 10(-8)) and MPHOSPH9/CDK2AP1 (P=3.96 x 10(-8)). The RGS1 risk allele is shared with celiac disease (CD), and the IL12A risk allele seems to be protective for celiac disease. Within the MPHOSPH9/CDK2AP1 locus, the risk allele correlates with diminished RNA expression of the cell cycle regulator CDK2AP1; this effect is seen in both lymphoblastic cell lines (P=1.18 x 10(-5)) and in peripheral blood mononuclear cells from subjects with MS (P=0.01). Thus, we report three new MS susceptibility loci, including a novel inflammatory disease locus that could affect autoreactive cell proliferation.

Citing Articles

Regulator of G-protein signaling 1 critically supports CD8 T cell-mediated intestinal immunity.

von Werdt D, Gungor B, Barreto de Albuquerque J, Gruber T, Zysset D, Kwong Chung C Front Immunol. 2023; 14:1085895.

PMID: 37153600 PMC: 10158727. DOI: 10.3389/fimmu.2023.1085895.

Differential DNA methylation associated with multiple sclerosis and disease modifying treatments in an underrepresented minority population.

Bingen J, Clark L, Band M, Munzir I, Carrithers M Front Genet. 2023; 13:1058817.

PMID: 36685876 PMC: 9845287. DOI: 10.3389/fgene.2022.1058817.

Transcriptome-wide association study reveals increased neuronal FLT3 expression is associated with Tourette's syndrome.

Liao C, Vuokila V, Catoire H, Akcimen F, Ross J, Bourassa C Commun Biol. 2022; 5(1):289.

PMID: 35354918 PMC: 8967882. DOI: 10.1038/s42003-022-03231-0.

RIPK1 activation mediates neuroinflammation and disease progression in multiple sclerosis.

Zelic M, Pontarelli F, Woodworth L, Zhu C, Mahan A, Ren Y Cell Rep. 2021; 35(6):109112.

PMID: 33979622 PMC: 8917516. DOI: 10.1016/j.celrep.2021.109112.

Cell-Type-Specific Gene Modules Related to the Regional Homogeneity of Spontaneous Brain Activity and Their Associations With Common Brain Disorders.

Shen J, Yang B, Xie Z, Wu H, Zheng Z, Wang J Front Neurosci. 2021; 15:639527.

PMID: 33958982 PMC: 8093778. DOI: 10.3389/fnins.2021.639527.

References

Kohno Y, Patel V, Kim Y, Tsuji T, Chin B, Sun M . Apoptosis, proliferation and p12(doc-1) profiles in normal, dysplastic and malignant squamous epithelium of the Syrian hamster cheek pouch model. Oral Oncol. 2002; 38(3):274-80. DOI: 10.1016/s1368-8375(01)00055-0. View

Aulchenko Y, Hoppenbrouwers I, Ramagopalan S, Broer L, Jafari N, Hillert J . Genetic variation in the KIF1B locus influences susceptibility to multiple sclerosis. Nat Genet. 2008; 40(12):1402-3. DOI: 10.1038/ng.251. View

Polman C, Reingold S, Edan G, Filippi M, Hartung H, Kappos L . Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria". Ann Neurol. 2005; 58(6):840-6. DOI: 10.1002/ana.20703. View

Barrett J, Hansoul S, Nicolae D, Cho J, Duerr R, Rioux J . Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease. Nat Genet. 2008; 40(8):955-62. PMC: 2574810. DOI: 10.1038/ng.175. View

Comabella M, Craig D, Camina-Tato M, Morcillo C, Lopez C, Navarro A . Identification of a novel risk locus for multiple sclerosis at 13q31.3 by a pooled genome-wide scan of 500,000 single nucleotide polymorphisms. PLoS One. 2008; 3(10):e3490. PMC: 2566815. DOI: 10.1371/journal.pone.0003490. View

Lundmark F, Duvefelt K, Iacobaeus E, Kockum I, Wallstrom E, Khademi M . Variation in interleukin 7 receptor alpha chain (IL7R) influences risk of multiple sclerosis. Nat Genet. 2007; 39(9):1108-13. DOI: 10.1038/ng2106. View

Jakkula E, Leppa V, Sulonen A, Varilo T, Kallio S, Kemppinen A . Genome-wide association study in a high-risk isolate for multiple sclerosis reveals associated variants in STAT3 gene. Am J Hum Genet. 2010; 86(2):285-91. PMC: 2820168. DOI: 10.1016/j.ajhg.2010.01.017. View

DAlfonso S, Bolognesi E, Guerini F, Barizzone N, Bocca S, Ferrante D . A sequence variation in the MOG gene is involved in multiple sclerosis susceptibility in Italy. Genes Immun. 2007; 9(1):7-15. DOI: 10.1038/sj.gene.6364437. View

Brok H, van Meurs M, Blezer E, Schantz A, Peritt D, Treacy G . Prevention of experimental autoimmune encephalomyelitis in common marmosets using an anti-IL-12p40 monoclonal antibody. J Immunol. 2002; 169(11):6554-63. DOI: 10.4049/jimmunol.169.11.6554. View

10.

Mantel N, Haenszel W . Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959; 22(4):719-48. View

11.

DerSimonian R, Laird N . Meta-analysis in clinical trials. Control Clin Trials. 1986; 7(3):177-88. DOI: 10.1016/0197-2456(86)90046-2. View

12.

Trynka G, Zhernakova A, Romanos J, Franke L, Hunt K, Turner G . Coeliac disease-associated risk variants in TNFAIP3 and REL implicate altered NF-kappaB signalling. Gut. 2009; 58(8):1078-83. DOI: 10.1136/gut.2008.169052. View

13.

Higgins J, Thompson S . Quantifying heterogeneity in a meta-analysis. Stat Med. 2002; 21(11):1539-58. DOI: 10.1002/sim.1186. View

14.

Trinchieri G . Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat Rev Immunol. 2003; 3(2):133-46. DOI: 10.1038/nri1001. View

15.

. Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20. Nat Genet. 2009; 41(7):824-8. DOI: 10.1038/ng.396. View

16.

Cenit M, Alcina A, Marquez A, Mendoza J, Diaz-Rubio M, de las Heras V . STAT3 locus in inflammatory bowel disease and multiple sclerosis susceptibility. Genes Immun. 2010; 11(3):264-8. DOI: 10.1038/gene.2010.10. View

17.

. The expanding genetic overlap between multiple sclerosis and type I diabetes. Genes Immun. 2008; 10(1):11-4. PMC: 2718424. DOI: 10.1038/gene.2008.83. View

18.

. Refining genetic associations in multiple sclerosis. Lancet Neurol. 2008; 7(7):567-9. PMC: 2696028. DOI: 10.1016/S1474-4422(08)70122-4. View

19.

McDonald W, Compston A, Edan G, Goodkin D, Hartung H, Lublin F . Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol. 2001; 50(1):121-7. DOI: 10.1002/ana.1032. View

20.

Baranzini S, Wang J, Gibson R, Galwey N, Naegelin Y, Barkhof F . Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis. Hum Mol Genet. 2008; 18(4):767-78. PMC: 4334814. DOI: 10.1093/hmg/ddn388. View